This document discusses Prenetics, a company that provides genetic testing and personalized health services. It lists the key members of Prenetics' commercial board and describes partnerships with major insurance companies. It also mentions a $10 million Series A investment from Ping An Ventures. The document introduces Prenetics' iGenes genetic pharmacogenomic test and myDNA mobile app, which provides personalized nutrition recommendations based on analysis of over 50 biomarkers and genetics. The myDNA app is presented as helping to increase customer acquisition, improve loyalty and reduce insurance claim costs.